Quoin Pharmaceuticals, Ltd. (QNRX)

USD 6.1

(-7.65%)

Operating Income Summary of Quoin Pharmaceuticals, Ltd.

  • Quoin Pharmaceuticals, Ltd.'s latest annual operating income in 2023 was -9.37 Million USD , down -5.99% from previous year.
  • Quoin Pharmaceuticals, Ltd.'s latest quarterly operating income in 2024 Q2 was -2.12 Million USD , up 14.33% from previous quarter.
  • Quoin Pharmaceuticals, Ltd. reported an annual operating income of -8.84 Million USD in 2022, up 56.56% from previous year.
  • Quoin Pharmaceuticals, Ltd. reported an annual operating income of -20.37 Million USD in 2021, down -894.57% from previous year.
  • Quoin Pharmaceuticals, Ltd. reported a quarterly operating income of -2.48 Million USD for 2024 Q1, down -10.88% from previous quarter.
  • Quoin Pharmaceuticals, Ltd. reported a quarterly operating income of -1.92 Million USD for 2023 Q3, up 8.56% from previous quarter.

Annual Operating Income Chart of Quoin Pharmaceuticals, Ltd. (2023 - 2015)

Historical Annual Operating Income of Quoin Pharmaceuticals, Ltd. (2023 - 2015)

Year Operating Income Operating Income Growth
2023 -9.37 Million USD -5.99%
2022 -8.84 Million USD 56.56%
2021 -20.37 Million USD -894.57%
2020 -2.04 Million USD -31.27%
2019 -1.56 Million USD -110.19%
2018 15.31 Million USD 50.58%
2017 10.17 Million USD -33.59%
2016 15.31 Million USD 689.46%
2015 -2.59 Million USD 0.0%

Peer Operating Income Comparison of Quoin Pharmaceuticals, Ltd.

Name Operating Income Operating Income Difference
Sangamo Therapeutics, Inc. -274 Million USD 96.577%
IDEAYA Biosciences, Inc. -134.42 Million USD 93.023%
Eton Pharmaceuticals, Inc. -1.19 Million USD -686.787%
Autolus Therapeutics plc -195.02 Million USD 95.191%
Greenwich LifeSciences, Inc. -9.32 Million USD -0.543%
Enlivex Therapeutics Ltd. -29.39 Million USD 68.095%
Shattuck Labs, Inc. -91.95 Million USD 89.801%
LENZ Therapeutics, Inc. -73.11 Million USD 87.172%
CervoMed Inc. -7.81 Million USD -20.039%
Rocket Pharmaceuticals, Inc. -259.65 Million USD 96.388%
Corbus Pharmaceuticals Holdings, Inc. -45.07 Million USD 79.195%
Aptose Biosciences Inc. -52.35 Million USD 82.087%
Precision BioSciences, Inc. -43.73 Million USD 78.557%
Dyadic International, Inc. -8.22 Million USD -13.959%
TScan Therapeutics, Inc. -93.45 Million USD 89.965%
Intensity Therapeutics, Inc. -8.31 Million USD -12.736%
Nektar Therapeutics -137.42 Million USD 93.176%
CytomX Therapeutics, Inc. -6.48 Million USD -44.641%
VYNE Therapeutics Inc. -29.25 Million USD 67.946%
EyePoint Pharmaceuticals, Inc. -73.66 Million USD 87.268%
Leap Therapeutics, Inc. -87.04 Million USD 89.225%
Adaptive Biotechnologies Corporation -227.03 Million USD 95.869%
GRI Bio, Inc. -11.38 Million USD 17.639%
Xenetic Biosciences, Inc. -4.51 Million USD -107.686%
Tenaya Therapeutics, Inc. -131.19 Million USD 92.851%
NeuroSense Therapeutics Ltd. -12.04 Million USD 22.164%
Psyence Biomedical Ltd. -2.75 Million USD -240.81%
IGM Biosciences, Inc. -263.46 Million USD 96.44%
INmune Bio, Inc. -29.74 Million USD 68.466%
Opthea Limited -191.84 Million USD 95.111%
Milestone Pharmaceuticals Inc. -61.09 Million USD 84.65%
Omega Therapeutics, Inc. -100.26 Million USD 90.646%
Verastem, Inc. -92.08 Million USD 89.815%
Abeona Therapeutics Inc. -47.13 Million USD 80.103%
Pliant Therapeutics, Inc. -184.14 Million USD 94.907%
Tonix Pharmaceuticals Holding Corp. -118.38 Million USD 92.078%
Ligand Pharmaceuticals Incorporated 11.94 Million USD 178.534%
NextCure, Inc. -67.63 Million USD 86.134%
Inhibikase Therapeutics, Inc. -20.08 Million USD 53.317%
Organovo Holdings, Inc. -15.08 Million USD 37.833%
Lixte Biotechnology Holdings, Inc. -5.09 Million USD -84.245%
Arvinas, Inc. -401.5 Million USD 97.664%
Ovid Therapeutics Inc. -59.28 Million USD 84.18%
CASI Pharmaceuticals, Inc. -25.28 Million USD 62.901%
Rani Therapeutics Holdings, Inc. -66.09 Million USD 85.811%
Centessa Pharmaceuticals plc -171.28 Million USD 94.525%
Arcturus Therapeutics Holdings Inc. -78.2 Million USD 88.008%
Syros Pharmaceuticals, Inc. -128.98 Million USD 92.729%
Senti Biosciences, Inc. -92.72 Million USD 89.886%
BioRestorative Therapies, Inc. -15.22 Million USD 38.384%
Apollomics, Inc. -54.83 Million USD 82.897%
PureTech Health plc -146.19 Million USD 93.585%
Oncternal Therapeutics, Inc. -41.71 Million USD 77.517%
Barinthus Biotherapeutics plc -83.91 Million USD 88.824%
Kymera Therapeutics, Inc. -165.53 Million USD 94.334%
Synaptogenix, Inc. -8.31 Million USD -12.806%
ChromaDex Corporation -5.59 Million USD -67.503%
Beam Therapeutics Inc. -176.48 Million USD 94.686%
Monopar Therapeutics Inc. -8.83 Million USD -6.197%
Akebia Therapeutics, Inc. -46.25 Million USD 79.725%
Nurix Therapeutics, Inc. -155.06 Million USD 93.952%
Apellis Pharmaceuticals, Inc. -517.12 Million USD 98.186%
Dermata Therapeutics, Inc. -8.04 Million USD -16.62%
Gritstone bio, Inc. -154.63 Million USD 93.935%
Mesoblast Limited -58.79 Million USD 84.049%
Virpax Pharmaceuticals, Inc. -15.68 Million USD 40.225%
Xeris Biopharma Holdings, Inc. -44.01 Million USD 78.69%
Fate Therapeutics, Inc. -190.51 Million USD 95.077%
MediWound Ltd. -15.29 Million USD 38.662%
BioXcel Therapeutics, Inc. -171.78 Million USD 94.54%
Fortress Biotech, Inc. -142.34 Million USD 93.411%
Fractyl Health, Inc. Common Stock -50.83 Million USD 81.551%
Achilles Therapeutics plc -75.25 Million USD 87.538%
Seres Therapeutics, Inc. -107.98 Million USD 91.315%
Checkpoint Therapeutics, Inc. -52.14 Million USD 82.016%
Atossa Therapeutics, Inc. -31.37 Million USD 70.11%
Zai Lab Limited -366.57 Million USD 97.442%
Fresh Tracks Therapeutics, Inc. -6.36 Million USD -47.461%
Lyell Immunopharma, Inc. -245.49 Million USD 96.18%
Vanda Pharmaceuticals Inc. -13.95 Million USD 32.78%
Tarsus Pharmaceuticals, Inc. -143.15 Million USD 93.449%
InMed Pharmaceuticals Inc. - USD Infinity%
FibroGen, Inc. -281.81 Million USD 96.672%
Celcuity Inc. -66.23 Million USD 85.84%
SeaStar Medical Holding Corporation -14.21 Million USD 34.001%
ContextLogic Inc. -328 Million USD 97.141%
GH Research PLC -41.22 Million USD 77.249%
HOOKIPA Pharma Inc. -97.69 Million USD 90.4%
Cyclacel Pharmaceuticals, Inc. -25.45 Million USD 63.154%
ImmuCell Corporation -5.74 Million USD -63.159%
Amylyx Pharmaceuticals, Inc. 38.8 Million USD 124.17%
Amarin Corporation plc -67.58 Million USD 86.124%
TG Therapeutics, Inc. 20.63 Million USD 145.454%
Aptevo Therapeutics Inc. -28.87 Million USD 67.524%
Jasper Therapeutics, Inc. -68.86 Million USD 86.381%
Foghorn Therapeutics Inc. -107.9 Million USD 91.309%
Y-mAbs Therapeutics, Inc. -25.67 Million USD 63.468%
Aptorum Group Limited -10.52 Million USD 10.879%
Ultragenyx Pharmaceutical Inc. -569.2 Million USD 98.352%
BioCryst Pharmaceuticals, Inc. -103.7 Million USD 90.957%
Chemomab Therapeutics Ltd. -25.45 Million USD 63.162%
Arrowhead Pharmaceuticals, Inc. -205 Million USD 95.425%
TransCode Therapeutics, Inc. -19.41 Million USD 51.703%
RAPT Therapeutics, Inc. -127.06 Million USD 92.619%
Ardelyx, Inc. -63.27 Million USD 85.178%
Ainos, Inc. -13.2 Million USD 28.985%
Lyra Therapeutics, Inc. -67.12 Million USD 86.027%
Prothena Corporation plc -191.03 Million USD 95.091%
HilleVax, Inc. -133.34 Million USD 92.967%
Adaptimmune Therapeutics plc -138.03 Million USD 93.206%
Celularity Inc. -192.28 Million USD 95.123%
Rallybio Corporation -78.93 Million USD 88.118%
Cue Biopharma, Inc. -52.14 Million USD 82.016%
Omeros Corporation -164.53 Million USD 94.3%
Humacyte, Inc. -100.04 Million USD 90.626%
Immunocore Holdings plc -59.64 Million USD 84.277%
Cocrystal Pharma, Inc. -18.55 Million USD 49.467%
Blueprint Medicines Corporation -486.27 Million USD 98.071%
IO Biotech, Inc. -91.44 Million USD 89.744%
MEI Pharma, Inc. 14.54 Million USD 164.493%
GT Biopharma, Inc. -13.57 Million USD 30.919%
Cabaletta Bio, Inc. -74.66 Million USD 87.438%
Summit Therapeutics Inc. -89.73 Million USD 89.549%
Alaunos Therapeutics, Inc. -34.26 Million USD 72.631%
Marinus Pharmaceuticals, Inc. -131.48 Million USD 92.867%
Scholar Rock Holding Corporation -171.29 Million USD 94.525%
Pulmatrix, Inc. -14.74 Million USD 36.374%
Elicio Therapeutics, Inc. -35.74 Million USD 73.763%
X4 Pharmaceuticals, Inc. -107.52 Million USD 91.278%
Vigil Neuroscience, Inc. -88.86 Million USD 89.446%
Acelyrin, Inc. -422.06 Million USD 97.778%
Intellia Therapeutics, Inc. -515.29 Million USD 98.18%
Cytokinetics, Incorporated -496.2 Million USD 98.11%
Vor Biopharma Inc. -126.03 Million USD 92.559%
Evogene Ltd. -26.39 Million USD 64.463%
Replimune Group, Inc. -234.77 Million USD 96.005%
Applied Therapeutics, Inc. -64.53 Million USD 85.468%
PDS Biotechnology Corporation -43.04 Million USD 78.212%
Hoth Therapeutics, Inc. -7.69 Million USD -21.922%
BridgeBio Pharma, Inc. -607.37 Million USD 98.456%
AEON Biopharma, Inc. -48.42 Million USD 80.635%
BioLineRx Ltd. -49.69 Million USD 81.127%
Galectin Therapeutics Inc. -38.07 Million USD 75.366%
Atai Life Sciences N.V. -125.47 Million USD 92.525%
Aerovate Therapeutics, Inc. -81.4 Million USD 88.48%
VistaGen Therapeutics, Inc. -33.02 Million USD 71.598%
Zentalis Pharmaceuticals, Inc. -248.98 Million USD 96.233%
Sagimet Biosciences Inc. -30.74 Million USD 69.491%
MediciNova, Inc. -9.9 Million USD 5.27%
Praxis Precision Medicines, Inc. -126.37 Million USD 92.579%
MiMedx Group, Inc. 37.11 Million USD 125.268%
Cardio Diagnostics Holdings, Inc. -7.24 Million USD -29.493%
Axsome Therapeutics, Inc. -231.82 Million USD 95.954%
PTC Therapeutics, Inc. -349.4 Million USD 97.316%
Mereo BioPharma Group plc -28.41 Million USD 66.996%
Syndax Pharmaceuticals, Inc. -229.95 Million USD 95.922%
NRx Pharmaceuticals, Inc. -27.58 Million USD 66.004%
Dyne Therapeutics, Inc. -242.16 Million USD 96.127%
BriaCell Therapeutics Corp. -4.79 Million USD -95.733%
Allakos Inc. -196.05 Million USD 95.216%
scPharmaceuticals Inc. -55.39 Million USD 83.07%
Fulcrum Therapeutics, Inc. -110.66 Million USD 91.525%
Corcept Therapeutics Incorporated 107.28 Million USD 108.742%
NLS Pharmaceutics AG -11.8 Million USD 20.569%
Precigen, Inc. -88.92 Million USD 89.453%
XOMA Corporation -41.84 Million USD 77.589%
Kezar Life Sciences, Inc. -105.23 Million USD 91.088%
Incyte Corporation 620.52 Million USD 101.511%
Alzamend Neuro, Inc. -9.93 Million USD 5.626%
Cara Therapeutics, Inc. -121.49 Million USD 92.281%
Aligos Therapeutics, Inc. -87.42 Million USD 89.273%
Seer, Inc. -103.46 Million USD 90.935%
Reviva Pharmaceuticals Holdings, Inc. -24.3 Million USD 61.416%
CRISPR Therapeutics AG -222.53 Million USD 95.786%
Akero Therapeutics, Inc. -172.87 Million USD 94.575%
Eliem Therapeutics, Inc. -21.46 Million USD 56.31%
EyeGate Pharmaceuticals, Inc. -8.21 Million USD -14.194%
Akari Therapeutics, Plc -16.8 Million USD 44.196%
Novavax, Inc. -566.51 Million USD 98.345%
Lexaria Bioscience Corp. -6.53 Million USD -43.533%
UroGen Pharma Ltd. -65.53 Million USD 85.69%
Sutro Biopharma, Inc. -89.27 Million USD 89.495%
Entera Bio Ltd. -8.89 Million USD -5.483%
Lisata Therapeutics, Inc. -25.7 Million USD 63.519%
Stoke Therapeutics, Inc. -114.77 Million USD 91.829%
Chimerix, Inc. -93.06 Million USD 89.923%
Reneo Pharmaceuticals, Inc. -83.05 Million USD 88.708%
Phathom Pharmaceuticals, Inc. -167.31 Million USD 94.395%
Outlook Therapeutics, Inc. -53.12 Million USD 82.347%
Jazz Pharmaceuticals plc 578.58 Million USD 101.621%
AnaptysBio, Inc. -164.41 Million USD 94.296%
Aprea Therapeutics, Inc. -15.47 Million USD 39.384%
Portage Biotech Inc. -18.25 Million USD 48.619%
Olema Pharmaceuticals, Inc. -104.96 Million USD 91.065%
PMV Pharmaceuticals, Inc. -80.13 Million USD 88.296%
OKYO Pharma Limited -15.74 Thousand USD -59447.078%
Qualigen Therapeutics, Inc. -11.3 Million USD 17.04%
Cadrenal Therapeutics, Inc. Common Stock -7.63 Million USD -22.87%
Processa Pharmaceuticals, Inc. -11.45 Million USD 18.142%
AbCellera Biologics Inc. -237.2 Million USD 96.046%
Genprex, Inc. -31.07 Million USD 69.82%
Neumora Therapeutics, Inc. Common Stock -188.19 Million USD 95.017%
NLS Pharmaceutics AG -11.8 Million USD 20.569%
Virios Therapeutics, Inc. -5.44 Million USD -72.18%
Daré Bioscience, Inc. -30.83 Million USD 69.59%
Titan Pharmaceuticals, Inc. -7.27 Million USD -28.879%
Bicycle Therapeutics plc -189.94 Million USD 95.063%
Revolution Medicines, Inc. Warrant -487.18 Million USD 98.075%
Protagonist Therapeutics, Inc. -93.65 Million USD 89.986%
Erasca, Inc. -141.52 Million USD 93.373%
bluebird bio, Inc. -244.26 Million USD 96.16%
Pieris Pharmaceuticals, Inc. -29.75 Million USD 68.482%
BioMarin Pharmaceutical Inc. 194.44 Million USD 104.823%
DBV Technologies S.A. -76.43 Million USD 87.73%
Fortress Biotech, Inc. -142.34 Million USD 93.411%
Avidity Biosciences, Inc. -235.59 Million USD 96.019%
CorMedix Inc. -48.95 Million USD 80.844%
Travere Therapeutics, Inc. -376.74 Million USD 97.511%
Sensei Biotherapeutics, Inc. -37.06 Million USD 74.696%
Orchestra BioMed Holdings, Inc. -51.5 Million USD 81.791%
Spruce Biosciences, Inc. -51.99 Million USD 81.962%
Celldex Therapeutics, Inc. -154.54 Million USD 93.931%
Cartesian Therapeutics, Inc. -86.41 Million USD 89.147%
Cogent Biosciences, Inc. -208.13 Million USD 95.494%
Onconetix, Inc. -36.03 Million USD 73.974%
Ocuphire Pharma, Inc. -10.56 Million USD 11.214%
Prime Medicine, Inc. -191.29 Million USD 95.097%
Adagene Inc. -23.71 Million USD 60.461%
Inhibrx Biosciences, Inc. -219.22 Million USD 95.722%
GlycoMimetics, Inc. -39.27 Million USD 76.121%
Maravai LifeSciences Holdings, Inc. -31.64 Million USD 70.366%
Verve Therapeutics, Inc. -223.12 Million USD 95.797%
Voyager Therapeutics, Inc. 122.01 Million USD 107.686%
SciSparc Ltd. -5.77 Million USD -62.455%
Revelation Biosciences, Inc. -8.65 Million USD -8.339%
Minerva Neurosciences, Inc. -23.11 Million USD 59.435%
Astria Therapeutics, Inc. -83.03 Million USD 88.705%
Spero Therapeutics, Inc. 21.48 Million USD 143.66%
Tevogen Bio Holdings Inc. -8843.03 USD -105955.323%
Arcutis Biotherapeutics, Inc. -241.1 Million USD 96.11%
Marker Therapeutics, Inc. -14.58 Million USD 35.682%
Alnylam Pharmaceuticals, Inc. -282.17 Million USD 96.676%
Artelo Biosciences, Inc. -10.28 Million USD 8.831%
2seventy bio, Inc. -216.7 Million USD 95.672%
ADMA Biologics, Inc. 21.63 Million USD 143.355%
Clene Inc. -40.54 Million USD 76.866%
Capricor Therapeutics, Inc. -24.07 Million USD 61.049%
Boundless Bio, Inc. Common Stock -54.79 Million USD 82.885%
Recursion Pharmaceuticals, Inc. -350.06 Million USD 97.321%
Citius Pharmaceuticals, Inc. -36.73 Million USD 74.468%
Contineum Therapeutics, Inc. Class A Common Stock 16.07 Million USD 158.335%
Absci Corporation -115.51 Million USD 91.881%
Regeneron Pharmaceuticals, Inc. 4.04 Billion USD 100.232%
Surrozen, Inc. -45.78 Million USD 79.514%
Caribou Biosciences, Inc. -116.05 Million USD 91.919%
Janux Therapeutics, Inc. -72.97 Million USD 87.149%
Cingulate Inc. -22.75 Million USD 58.792%
Galmed Pharmaceuticals Ltd. 7.49 Million USD 225.18%
Tenax Therapeutics, Inc. -8.23 Million USD -13.901%
Jaguar Health, Inc. -34.29 Million USD 72.65%
Terns Pharmaceuticals, Inc. -102.55 Million USD 90.855%
ACADIA Pharmaceuticals Inc. -73.37 Million USD 87.219%
Kronos Bio, Inc. -121.83 Million USD 92.302%
Innoviva, Inc. 176.7 Million USD 105.307%
Bolt Biotherapeutics, Inc. -76.19 Million USD 87.692%
Entrada Therapeutics, Inc. -3.16 Million USD -196.6%
ZyVersa Therapeutics, Inc. -14.42 Million USD 34.965%
Soligenix, Inc. -7.69 Million USD -21.831%
AlloVir, Inc. -181.33 Million USD 94.828%
Century Therapeutics, Inc. -146.54 Million USD 93.6%
ORIC Pharmaceuticals, Inc. -110.78 Million USD 91.534%
Kura Oncology, Inc. -165.8 Million USD 94.344%
Ocean Biomedical, Inc. -2.48 Million USD -277.916%
Mineralys Therapeutics, Inc. -84.65 Million USD 88.922%
Eterna Therapeutics Inc. -21.13 Million USD 55.626%
SELLAS Life Sciences Group, Inc. -37.86 Million USD 75.234%
Heron Therapeutics, Inc. -110.61 Million USD 91.521%
SAB Biotherapeutics, Inc. -38.07 Million USD 75.369%
Pasithea Therapeutics Corp. -15.97 Million USD 41.309%
Entero Therapeutics, Inc. -15.77 Million USD 40.533%
HCW Biologics Inc. -25.71 Million USD 63.532%
C4 Therapeutics, Inc. -139.03 Million USD 93.254%
Atara Biotherapeutics, Inc. -276 Million USD 96.602%
Coherus BioSciences, Inc. -203.19 Million USD 95.385%
Lantern Pharma Inc. -17.87 Million USD 47.54%
Histogen Inc. -10.64 Million USD 11.881%
Surrozen, Inc. -45.78 Million USD 79.514%
Eledon Pharmaceuticals, Inc. -43 Million USD 78.19%
Kodiak Sciences Inc. -277.32 Million USD 96.618%
MoonLake Immunotherapeutics -54.12 Million USD 82.672%
Hepion Pharmaceuticals, Inc. -48.44 Million USD 80.642%
Adverum Biotechnologies, Inc. -123.79 Million USD 92.424%
Avalo Therapeutics, Inc. -23.44 Million USD 59.996%
Moderna, Inc. -4.23 Billion USD 99.779%
Ionis Pharmaceuticals, Inc. -353.73 Million USD 97.349%
Turnstone Biologics Corp. -59.03 Million USD 84.113%
Immix Biopharma, Inc. -16.14 Million USD 41.897%
Tiziana Life Sciences Ltd -14.58 Million USD 35.702%
Aurinia Pharmaceuticals Inc. -91.69 Million USD 89.772%
Exelixis, Inc. 170.88 Million USD 105.488%
Monte Rosa Therapeutics, Inc. -143.31 Million USD 93.456%
Wave Life Sciences Ltd. -67.99 Million USD 86.207%
Conduit Pharmaceuticals Inc. -5.56 Million USD -68.617%
Alkermes plc 414.12 Million USD 102.265%
Jasper Therapeutics, Inc. -68.86 Million USD 86.381%
Arcellx, Inc. -89.88 Million USD 89.566%
ESSA Pharma Inc. -32.13 Million USD 70.814%
TNF Pharmaceuticals, Inc. -17.12 Million USD 45.229%
Avid Bioservices, Inc. -18.67 Million USD 49.788%
Insmed Incorporated -709.62 Million USD 98.678%
Cardiff Oncology, Inc. -45.41 Million USD 79.348%
Enanta Pharmaceuticals, Inc. -137.2 Million USD 93.165%
Moolec Science SA -6.65 Million USD -40.949%
RenovoRx, Inc. -11.39 Million USD 17.704%
Acumen Pharmaceuticals, Inc. -61.13 Million USD 84.66%
Geron Corporation -193.94 Million USD 95.164%
LAVA Therapeutics N.V. -43.25 Million USD 78.317%
Verrica Pharmaceuticals Inc. -65.75 Million USD 85.738%
Royalty Pharma plc 1.49 Billion USD 100.629%
OmniAb, Inc. -69.41 Million USD 86.49%
Alector, Inc. -151.74 Million USD 93.819%
Atea Pharmaceuticals, Inc. -164.16 Million USD 94.287%
Mersana Therapeutics, Inc. -170.95 Million USD 94.514%
Humacyte, Inc. -100.04 Million USD 90.626%
Structure Therapeutics Inc. -102.77 Million USD 90.875%
Revance Therapeutics, Inc. -316.77 Million USD 97.039%
89bio, Inc. -151.2 Million USD 93.797%
Avenue Therapeutics, Inc. -14.54 Million USD 35.499%
Aura Biosciences, Inc. -84.99 Million USD 88.965%
Immunic, Inc. -99.22 Million USD 90.548%
Veracyte, Inc. -85.79 Million USD 89.069%
Genelux Corporation -24.16 Million USD 61.19%
Trevi Therapeutics, Inc. -33.92 Million USD 72.354%
Adial Pharmaceuticals, Inc. -6.88 Million USD -36.158%
Sonnet BioTherapeutics Holdings, Inc. -18.79 Million USD 50.095%
Immunovant, Inc. -282.7 Million USD 96.683%
Vericel Corporation -6.46 Million USD -45.088%
Fortrea Holdings Inc. 63.1 Million USD 114.863%
KalVista Pharmaceuticals, Inc. -140.44 Million USD 93.322%
XBiotech Inc. -37.51 Million USD 74.997%
Agenus Inc. -159.54 Million USD 94.122%
Acasti Pharma Inc. -11.31 Million USD 17.092%
Kiora Pharmaceuticals, Inc. -12.58 Million USD 25.49%
MiNK Therapeutics, Inc. -22.92 Million USD 59.084%
Pasithea Therapeutics Corp. -15.97 Million USD 41.309%
Theravance Biopharma, Inc. -53.29 Million USD 82.402%
Metagenomi, Inc. Common Stock -78.49 Million USD 88.052%
NeuroBo Pharmaceuticals, Inc. -15.88 Million USD 40.964%
Gain Therapeutics, Inc. -22.25 Million USD 57.855%
Tempest Therapeutics, Inc. -29.15 Million USD 67.834%
Sol-Gel Technologies Ltd. -29.3 Million USD 67.997%
Rhythm Pharmaceuticals, Inc. -184.35 Million USD 94.913%
United Therapeutics Corporation 1.18 Billion USD 100.792%
Creative Medical Technology Holdings, Inc. -5.62 Million USD -66.873%
BriaCell Therapeutics Corp. -32.8 Million USD 71.414%
Lixte Biotechnology Holdings, Inc. -5.09 Million USD -84.245%
Silo Pharma, Inc. -3.85 Million USD -143.244%
Telomir Pharmaceuticals, Inc. Common Stock -3.94 Million USD -137.909%
Pharming Group N.V. -4.87 Million USD -92.2%
XOMA Corporation -41.84 Million USD 77.589%
Reviva Pharmaceuticals Holdings, Inc. -24.3 Million USD 61.416%
Bionomics Limited -17.89 Billion USD 99.948%
Alpha Tau Medical Ltd. 35.68 Million USD 126.285%
Pyxis Oncology, Inc. -82.19 Million USD 88.59%
uniQure N.V. -282.87 Million USD 96.685%
Xilio Therapeutics, Inc. -79.13 Million USD 88.148%
Cassava Sciences, Inc. -105.95 Million USD 91.149%
60 Degrees Pharmaceuticals, Inc. -5.15 Million USD -81.945%
Windtree Therapeutics, Inc. -17.53 Million USD 46.528%
Poseida Therapeutics, Inc. -129.5 Million USD 92.758%
Pluri Inc. -22.15 Million USD 57.674%
Anebulo Pharmaceuticals, Inc. -8.3 Million USD -12.875%
MeiraGTx Holdings plc -137.06 Million USD 93.157%
Cidara Therapeutics, Inc. -24.48 Million USD 61.694%
ProMIS Neurosciences, Inc. -18.89 Million USD 50.372%
CalciMedica, Inc. -21.87 Million USD 57.127%
Sana Biotechnology, Inc. -326.9 Million USD 97.131%
Amicus Therapeutics, Inc. -73.49 Million USD 87.239%
Salarius Pharmaceuticals, Inc. -12.89 Thousand USD -72630.11%
Alpha Tau Medical Ltd. 35.68 Million USD 126.285%
Adlai Nortye Ltd. American Depositary Shares -67.55 Million USD 86.116%
Nutriband Inc. -4.87 Million USD -92.501%
Protara Therapeutics, Inc. -43.61 Million USD 78.496%
Compugen Ltd. -12.99 Million USD 27.813%
Roivant Sciences Ltd. 4.24 Billion USD 100.221%
ProKidney Corp. -151.52 Million USD 93.81%
Protagenic Therapeutics, Inc. -4.52 Million USD -107.169%
Elevai Labs, Inc. Common Stock -3.66 Million USD -155.61%
Tango Therapeutics, Inc. -114.17 Million USD 91.786%
Renovaro Biosciences Inc. -81.63 Million USD 88.512%
Zevra Therapeutics, Inc. -49.6 Million USD 81.093%
Benitec Biopharma Inc. -22.49 Million USD 58.299%
GeoVax Labs, Inc. -26.74 Million USD 64.931%
Biomea Fusion, Inc. -126.13 Million USD 92.565%
Cullinan Oncology, Inc. -191.08 Million USD 95.092%
4D Molecular Therapeutics, Inc. -112.86 Million USD 91.691%
Kiniksa Pharmaceuticals, Ltd. -25.19 Million USD 62.778%
Nuvectis Pharma, Inc. -22.89 Million USD 59.04%
Spyre Therapeutics, Inc. -242.3 Million USD 96.129%
Ventyx Biosciences, Inc. -207.99 Million USD 95.491%
Imunon, Inc. -21.03 Million USD 55.405%
BioAtla, Inc. -129.68 Million USD 92.768%
Allogene Therapeutics, Inc. -327.73 Million USD 97.138%
Larimar Therapeutics, Inc. -41.75 Million USD 77.541%
Zura Bio Limited -62.63 Million USD 85.027%
aTyr Pharma, Inc. -54.91 Million USD 82.923%
Madrigal Pharmaceuticals, Inc. -380.49 Million USD 97.535%
Viridian Therapeutics, Inc. -254.45 Million USD 96.314%
Galecto, Inc. -39.9 Million USD 76.498%
Tevogen Bio Holdings Inc. -8843.03 USD -105955.323%
Halozyme Therapeutics, Inc. 337.57 Million USD 102.778%
Lexicon Pharmaceuticals, Inc. -171.75 Million USD 94.539%
PolyPid Ltd. -22.86 Million USD 58.987%
Aileron Therapeutics, Inc. -16.27 Million USD 42.378%
Forte Biosciences, Inc. -32.48 Million USD 71.131%
Xencor, Inc. -138.63 Million USD 93.235%
Coeptis Therapeutics Holdings, Inc. -21.49 Million USD 56.361%
Lexaria Bioscience Corp. -6.53 Million USD -43.533%
Instil Bio, Inc. -159.16 Million USD 94.108%
Cardio Diagnostics Holdings, Inc. -7.24 Million USD -29.493%
OncoCyte Corporation -25.13 Million USD 62.689%
Elevation Oncology, Inc. -45.44 Million USD 79.363%
Purple Biotech Ltd. 22.27 Million USD 142.111%
CollPlant Biotechnologies Ltd. -7.51 Million USD -24.847%
MacroGenics, Inc. -168.24 Million USD 94.426%
Verona Pharma plc -67.83 Million USD 86.174%
Tharimmune, Inc. -9.45 Million USD 0.811%
Apogee Therapeutics, Inc. -93 Million USD 89.916%
enGene Holdings Inc. Warrants -26.06 Million USD 64.012%
Aditxt, Inc. -26.06 Million USD 64.015%
XTL Biopharmaceuticals Ltd. -765 Thousand USD -1125.948%
Savara Inc. -60 Million USD 84.371%
Curis, Inc. -48.33 Million USD 80.596%
Carmell Therapeutics Corporation -5.21 Million USD -79.758%
Achieve Life Sciences, Inc. -27.25 Million USD 65.583%
BeiGene, Ltd. -1.2 Billion USD 99.223%
Protagenic Therapeutics, Inc. -4.52 Million USD -107.169%
Vincerx Pharma, Inc. -42.6 Million USD 77.989%
Plus Therapeutics, Inc. -13.32 Million USD 29.596%
Acrivon Therapeutics, Inc. Common Stock -67.23 Million USD 86.052%
Rigel Pharmaceuticals, Inc. -20.49 Million USD 54.231%
Adicet Bio, Inc. -152.03 Million USD 93.831%
Estrella Immunopharma, Inc. -7.31 Million USD -28.295%
Quantum-Si incorporated -111.17 Million USD 91.564%
Acurx Pharmaceuticals, Inc. -14.57 Million USD 35.666%
Generation Bio Co. -138.56 Million USD 93.232%
Black Diamond Therapeutics, Inc. -86.46 Million USD 89.153%
Invivyd, Inc. -207.78 Million USD 95.486%
Relay Therapeutics, Inc. -373 Million USD 97.486%
Moolec Science SA -6.65 Million USD -40.949%
Clearside Biomedical, Inc. -24.84 Million USD 62.25%
Longboard Pharmaceuticals, Inc. -56.75 Million USD 83.477%
Relmada Therapeutics, Inc. -103.7 Million USD 90.956%
ALX Oncology Holdings Inc. -170.27 Million USD 94.492%
Vir Biotechnology, Inc. -684.3 Million USD 98.629%
Evaxion Biotech A/S -22.19 Million USD 57.749%
Ocular Therapeutix, Inc. -82.38 Million USD 88.616%
Tyra Biosciences, Inc. -79.94 Million USD 88.269%
Unity Biotechnology, Inc. -44.66 Million USD 79.004%
Connect Biopharma Holdings Limited -62.07 Million USD 84.891%
Clearmind Medicine Inc. -8.74 Million USD -7.289%
Aadi Bioscience, Inc. -71.93 Million USD 86.962%
Catalyst Pharmaceuticals, Inc. 86.81 Million USD 110.803%
CERo Therapeutics Holdings, Inc. -2.93 Million USD -219.76%
Viking Therapeutics, Inc. -100.82 Million USD 90.698%
Keros Therapeutics, Inc. -169.94 Million USD 94.481%
Crinetics Pharmaceuticals, Inc. -222.6 Million USD 95.787%
ImmunityBio, Inc. -362.25 Million USD 97.411%
Korro Bio, Inc. -84.53 Million USD 88.906%
Kineta, Inc. -15.72 Million USD 40.352%
BioVie Inc. -32.17 Million USD 70.856%
Codexis, Inc. -68.06 Million USD 86.222%
Celularity Inc. -192.28 Million USD 95.123%
Virax Biolabs Group Limited -6.49 Million USD -44.363%
Cibus, Inc. -318.88 Million USD 97.059%
Annexon, Inc. -143.72 Million USD 93.475%
Assembly Biosciences, Inc. -64.64 Million USD 85.493%
Eyenovia, Inc. -25.4 Million USD 63.086%
Puma Biotechnology, Inc. 32.64 Million USD 128.733%
NeurAxis, Inc. -6.66 Million USD -40.723%
Regulus Therapeutics Inc. -31.1 Million USD 69.853%
Compass Therapeutics, Inc. -50.36 Million USD 81.378%
TFF Pharmaceuticals, Inc. -21.89 Million USD 57.165%
Notable Labs, Ltd. -14.65 Million USD 36.013%
IN8bio, Inc. -30.33 Million USD 69.086%
DiaMedica Therapeutics Inc. -21.26 Million USD 55.901%
Vera Therapeutics, Inc. -102.01 Million USD 90.806%
Lumos Pharma, Inc. -36.61 Million USD 74.385%
Liquidia Corporation -73.38 Million USD 87.22%
Mustang Bio, Inc. -50.72 Million USD 81.511%
Quantum-Si incorporated -111.17 Million USD 91.564%
Arbutus Biopharma Corporation -78.1 Million USD 87.992%
enGene Holdings Inc. Common Stock -26.06 Million USD 64.012%
ARS Pharmaceuticals, Inc. -67.52 Million USD 86.11%
180 Life Sciences Corp. -13.47 Million USD 30.414%
Vaxcyte, Inc. -468.04 Million USD 97.996%
Xenon Pharmaceuticals Inc. -214.05 Million USD 95.619%
Estrella Immunopharma, Inc. -7.31 Million USD -28.295%
NKGen Biotech, Inc. Warrants -29.74 Million USD 68.471%
Opiant Pharmaceuticals, Inc. 5.15 Million USD 281.884%
CERo Therapeutics Holdings, Inc. -2.93 Million USD -219.76%
Soleno Therapeutics, Inc. -41.38 Million USD 77.338%
PepGen Inc. -84.76 Million USD 88.936%
Moleculin Biotech, Inc. -29.63 Million USD 68.349%
Solid Biosciences Inc. -104.31 Million USD 91.009%
Palisade Bio, Inc. -13.07 Million USD 28.244%
Nutriband Inc. -4.87 Million USD -92.501%
Conduit Pharmaceuticals Inc. -5.56 Million USD -68.617%
Immuneering Corporation -58.41 Million USD 83.944%
Belite Bio, Inc -31.66 Million USD 70.385%
CG Oncology, Inc. Common stock -55.44 Million USD 83.086%
GeoVax Labs, Inc. -26.74 Million USD 64.931%
Tourmaline Bio, Inc. -45.4 Million USD 79.347%
Altimmune, Inc. -95.92 Million USD 90.223%
Peak Bio, Inc. -1356.23 USD -691412.797%
SeaStar Medical Holding Corporation -14.21 Million USD 34.001%
FibroBiologics, Inc. Common Stock -8.88 Million USD -5.507%
Neurogene Inc. -55.58 Million USD 83.127%
Mirum Pharmaceuticals, Inc. -109.15 Million USD 91.408%
Kintara Therapeutics, Inc. -8.5 Million USD -10.322%
CARGO Therapeutics, Inc. Common Stock -96.71 Million USD 90.302%
Sesen Bio, Inc. -25.9 Million USD 63.802%
argenx SE -425.04 Million USD 97.794%
NKGen Biotech, Inc. Common Stock -29.74 Million USD 68.471%
Dianthus Therapeutics, Inc. -48.17 Million USD 80.532%
Immunome, Inc. -109.53 Million USD 91.438%
Enveric Biosciences, Inc. -16.44 Million USD 42.982%
Design Therapeutics, Inc. -78.19 Million USD 88.005%
Seelos Therapeutics, Inc. -40.49 Million USD 76.843%
Enliven Therapeutics, Inc. -83.52 Million USD 88.772%
Iovance Biotherapeutics, Inc. -460.55 Million USD 97.964%
Taysha Gene Therapies, Inc. -72.43 Million USD 87.053%
Inovio Pharmaceuticals, Inc. -135.22 Million USD 93.065%
Athira Pharma, Inc. -125.46 Million USD 92.525%
XOMA Corporation -41.84 Million USD 77.589%
Merus N.V. -156.54 Million USD 94.009%
Quince Therapeutics, Inc. -34.62 Million USD 72.91%
Rezolute, Inc. -70.42 Million USD 86.683%
Clene Inc. -40.54 Million USD 76.866%
Indaptus Therapeutics, Inc. -16.37 Million USD 42.739%
BeyondSpring Inc. -23.11 Million USD 59.425%
Synlogic, Inc. -55.16 Million USD 82.998%
Allarity Therapeutics, Inc. -17.92 Million USD 47.691%
Phio Pharmaceuticals Corp. -10.82 Million USD 13.355%
Peak Bio, Inc. -1356.23 USD -691412.797%
Werewolf Therapeutics, Inc. -40.5 Million USD 76.845%
Krystal Biotech, Inc. -109.72 Million USD 91.453%
Karyopharm Therapeutics Inc. -129.53 Million USD 92.76%
SpringWorks Therapeutics, Inc. -343.01 Million USD 97.266%
Lipella Pharmaceuticals Inc. -4.74 Million USD -97.611%
MannKind Corporation 8.67 Million USD 208.072%
Ikena Oncology, Inc. -75.41 Million USD 87.564%
Cyclerion Therapeutics, Inc. -9.64 Million USD 2.783%
Gyre Therapeutics, Inc. -67.23 Million USD 86.05%
Gossamer Bio, Inc. -183.75 Million USD 94.896%
CohBar, Inc. -12.38 Million USD 24.295%
Cognition Therapeutics, Inc. -50.72 Million USD 81.511%
NRx Pharmaceuticals, Inc. -27.58 Million USD 66.004%
Legend Biotech Corporation -439.48 Million USD 97.866%
Mural Oncology plc -194.63 Million USD 95.182%
Disc Medicine, Inc. -91.12 Million USD 89.708%
Champions Oncology, Inc. -7.35 Million USD -27.495%
REGENXBIO Inc. -268.12 Million USD 96.502%
Ensysce Biosciences, Inc. -10.71 Million USD 12.499%
Anavex Life Sciences Corp. -55.75 Million USD 83.179%
Cellectar Biosciences, Inc. -38.96 Million USD 75.928%
Edgewise Therapeutics, Inc. -114.35 Million USD 91.799%
Vaxart, Inc. -83.34 Million USD 88.748%
PharmaCyte Biotech, Inc. -8.52 Million USD -10.076%
Aldeyra Therapeutics, Inc. -42.79 Million USD 78.085%
Cellectis S.A. -106.62 Million USD 91.204%
Longeveron Inc. -21.02 Million USD 55.402%
Repare Therapeutics Inc. -116.22 Million USD 91.931%
Sarepta Therapeutics, Inc. -267.82 Million USD 96.498%
Inozyme Pharma, Inc. -75.64 Million USD 87.602%
Revolution Medicines, Inc. -487.18 Million USD 98.075%
Nymox Pharmaceutical Corporation -6.65 Million USD -40.988%
Third Harmonic Bio, Inc. -43.95 Million USD 78.663%
ArriVent BioPharma, Inc. Common Stock -74.59 Million USD 87.427%
AN2 Therapeutics, Inc. -69.63 Million USD 86.532%
Anixa Biosciences, Inc. -11.01 Million USD 14.826%
Vertex Pharmaceuticals Incorporated 4.3 Billion USD 100.218%
Denali Therapeutics Inc. -196.69 Million USD 95.232%
Revelation Biosciences, Inc. -8.65 Million USD -8.339%
Veru Inc. -93.78 Million USD 90.0%
Corvus Pharmaceuticals, Inc. -23.32 Million USD 59.799%
Cingulate Inc. -22.75 Million USD 58.792%
Passage Bio, Inc. -108.38 Million USD 91.347%
Context Therapeutics Inc. -25.07 Million USD 62.595%
Exicure, Inc. -14.99 Million USD 37.46%
Day One Biopharmaceuticals, Inc. -206.06 Million USD 95.449%
Oramed Pharmaceuticals Inc. -40.59 Million USD 76.899%
Scinai Immunotherapeutics Ltd. -9.71 Million USD 3.483%
Nuvalent, Inc. -149.49 Million USD 93.726%
ABVC BioPharma, Inc. -8.21 Million USD -14.142%
Carisma Therapeutics, Inc. -88.73 Million USD 89.43%
Unicycive Therapeutics, Inc. -20.77 Million USD 54.855%
OmniAb, Inc. -69.41 Million USD 86.49%
Anew Medical, Inc. -1.3 Million USD -620.958%
Fennec Pharmaceuticals Inc. -12.77 Million USD 26.564%
Lipocine Inc. -17.93 Million USD 47.697%
Lexeo Therapeutics, Inc. Common Stock -68.51 Million USD 86.311%
Nautilus Biotechnology, Inc. -76.15 Million USD 87.684%
SAB Biotherapeutics, Inc. -38.07 Million USD 75.369%
G1 Therapeutics, Inc. -39.52 Million USD 76.273%
Bellerophon Therapeutics, Inc. -22.38 Million USD 58.102%
Sage Therapeutics, Inc. -579.84 Million USD 98.383%
Ocugen, Inc. -65.53 Million USD 85.688%
Mind Medicine (MindMed) Inc. -93.86 Million USD 90.009%
Q32 Bio Inc. -92.1 Million USD 89.817%
Brainstorm Cell Therapeutics Inc. -21.43 Million USD 56.255%
Alumis Inc. Common Stock -158.17 Million USD 94.071%
Equillium, Inc. -14.52 Million USD 35.419%
Kyverna Therapeutics, Inc. -62.4 Million USD 84.972%
Coya Therapeutics, Inc. -7.9 Million USD -18.665%
CNS Pharmaceuticals, Inc. -18.86 Million USD 50.287%
Dominari Holdings Inc. -21.79 Million USD 56.971%
Edesa Biotech, Inc. -9.22 Million USD -1.689%
vTv Therapeutics Inc. -25.5 Million USD 63.224%
Bio-Techne Corporation 206.68 Million USD 104.538%
Agios Pharmaceuticals, Inc. -391.48 Million USD 97.604%
Harmony Biosciences Holdings, Inc. 192.03 Million USD 104.884%
Prelude Therapeutics Incorporated -132.27 Million USD 92.91%
Candel Therapeutics, Inc. -38.39 Million USD 75.571%
iTeos Therapeutics, Inc. -151.1 Million USD 93.793%
Nkarta, Inc. -131.65 Million USD 92.876%
BioCardia, Inc. -11.64 Million USD 19.456%
Iterum Therapeutics plc -47.46 Million USD 80.242%